Funny how when we get momentous news, all of a sudden the stupid food fight resurfaces, over an argument that can never be resolved.

Let me remind everyone: the company is moving ahead dramatically with the sachet formulation of Brilacidin-OM which will enable the Phase 3 trial to proceed. That trial should go very quickly.

And, as Ultimate pointed out, it is possible that the company may be able to let patients use this soon, if the compassionate-use provisions are hammered out.